1H-Pyrrolo[3,2-b]pyridine-2-carbaldehyde

Catalog No. :
ACOXPU803
CAS No. :
17288-52-7
Molecular Formula :
C8H6N2O
Molecular Weight :
146.15

IUPAC Name:1H-pyrrolo[3,2-b]pyridine-2-carbaldehyde

1H-Pyrrolo[3,2-b]pyridine-2-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$56.00Login to see priceIn stockIn stock
250mg97%$110.00Login to see priceIn stockIn stock
1g97%$308.00Login to see priceIn stockIn stock
5g97%$1494.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1H-Pyrrolo[3,2-b]pyridine-2-carbaldehyde
IUPAC Name1H-pyrrolo[3,2-b]pyridine-2-carbaldehyde
MDL No.MFCD08437635
Molecular FormulaC8H6N2O
Molecular Weight146.15
SMILESO=CC1=CC2=NC=CC=C2N1
InChI KeyDQSXESUAVDEVJI-UHFFFAOYSA-N
SynonymSCHEMBL4278906 | 1H-pyrrolo[3,2-b]pyridine-2-carbaldehyde | AMY24509 | DQSXESUAVDEVJI-UHFFFAOYSA-N | 4-azaindole-2-carbaldehyde | SY068137 | SB15793 | MFCD08437635 | 1H-pyrrolo[3,2-b]pyridine-2-carboxaldehyde | AKOS006290872 | AS-30598
CAS No.17288-52-7
PubChem CID22281739

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACOXPU803 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRATU104 route compound structure diagram
    ACRATU104394223-19-9 In Stock
  2. Plus
  3. ACEGRF517 route compound structure diagram
    ACEGRF5177782-64-1
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACOXPU803 route product structure diagram
    ACOXPU80317288-52-7 In Stock
Inquiry

2. ACOXPU803 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYGPK084 route compound structure diagram
    ACYGPK08417288-47-0 In Stock
  2. Then
  3. ACOXPU803 route product structure diagram
    ACOXPU80317288-52-7 In Stock
Inquiry

Comments (0)